A  ||| S:0 E:2 ||| DT
randomised  ||| S:2 E:13 ||| JJ
clinical  ||| S:13 E:22 ||| JJ
trial  ||| S:22 E:28 ||| NN
on  ||| S:28 E:31 ||| IN
the  ||| S:31 E:35 ||| DT
efficacy  ||| S:35 E:44 ||| NN
of  ||| S:44 E:47 ||| IN
oxytetracycline  ||| S:47 E:63 ||| JJ
dose  ||| S:63 E:68 ||| NN
through  ||| S:68 E:76 ||| IN
water  ||| S:76 E:82 ||| NN
medication  ||| S:82 E:93 ||| NN
of  ||| S:93 E:96 ||| IN
nursery  ||| S:96 E:104 ||| JJ
pigs  ||| S:104 E:109 ||| NNS
on  ||| S:109 E:112 ||| IN
diarrhoea ||| S:112 E:121 ||| NN
,  ||| S:121 E:123 ||| ,
faecal  ||| S:123 E:130 ||| VBZ
shedding  ||| S:130 E:139 ||| VBG
of  ||| S:139 E:142 ||| IN
Lawsonia  ||| S:142 E:151 ||| NNP
intracellularis  ||| S:151 E:167 ||| NN
and  ||| S:167 E:171 ||| CC
average  ||| S:171 E:179 ||| JJ
daily  ||| S:179 E:185 ||| JJ
weight  ||| S:185 E:192 ||| NN
gain  ||| S:192 E:197 ||| NN
Oral  ||| S:197 E:202 ||| NNP
treatment  ||| S:202 E:212 ||| NN
with  ||| S:212 E:217 ||| IN
antimicrobials  ||| S:217 E:232 ||| NN
is  ||| S:232 E:235 ||| VBZ
widely  ||| S:235 E:242 ||| RB
used  ||| S:242 E:247 ||| VBN
in  ||| S:247 E:250 ||| IN
pig  ||| S:250 E:254 ||| JJ
production  ||| S:254 E:265 ||| NN
for  ||| S:265 E:269 ||| IN
the  ||| S:269 E:273 ||| DT
control  ||| S:273 E:281 ||| NN
of  ||| S:281 E:284 ||| IN
gastrointestinal  ||| S:284 E:301 ||| JJ
infections ||| S:301 E:311 ||| NNS
.  ||| S:311 E:313 ||| .
Lawsonia  ||| S:313 E:322 ||| JJ
intracellularis  ||| S:322 E:338 ||| NNS
( ||| S:338 E:339 ||| -LRB-
LI ||| S:339 E:341 ||| NNP
)  ||| S:341 E:343 ||| -RRB-
causes  ||| S:343 E:350 ||| VBZ
enteritis  ||| S:350 E:360 ||| VBN
in  ||| S:360 E:363 ||| IN
pigs  ||| S:363 E:368 ||| NNS
older  ||| S:368 E:374 ||| JJR
than  ||| S:374 E:379 ||| IN
six  ||| S:379 E:383 ||| CD
weeks  ||| S:383 E:389 ||| NNS
of  ||| S:389 E:392 ||| IN
age  ||| S:392 E:396 ||| NN
and  ||| S:396 E:400 ||| CC
is  ||| S:400 E:403 ||| VBZ
commonly  ||| S:403 E:412 ||| RB
treated  ||| S:412 E:420 ||| VBN
with  ||| S:420 E:425 ||| IN
antimicrobials ||| S:425 E:439 ||| NN
.  ||| S:439 E:441 ||| .
The  ||| S:441 E:445 ||| DT
objective  ||| S:445 E:455 ||| NN
of  ||| S:455 E:458 ||| IN
this  ||| S:458 E:463 ||| DT
study  ||| S:463 E:469 ||| NN
was  ||| S:469 E:473 ||| VBD
to  ||| S:473 E:476 ||| TO
evaluate  ||| S:476 E:485 ||| VB
the  ||| S:485 E:489 ||| DT
efficacy  ||| S:489 E:498 ||| NN
of  ||| S:498 E:501 ||| IN
three  ||| S:501 E:507 ||| CD
oral  ||| S:507 E:512 ||| JJ
dosage  ||| S:512 E:519 ||| NN
regimens  ||| S:519 E:528 ||| NNS
( ||| S:528 E:529 ||| -LRB-
5 ||| S:529 E:530 ||| CD
,  ||| S:530 E:532 ||| ,
10  ||| S:532 E:535 ||| CD
and  ||| S:535 E:539 ||| CC
20mg ||| S:539 E:543 ||| CD
/ ||| S:543 E:544 ||| CD
kg  ||| S:544 E:547 ||| JJ
body  ||| S:547 E:552 ||| NN
weight ||| S:552 E:558 ||| NN
)  ||| S:558 E:560 ||| -RRB-
of  ||| S:560 E:563 ||| IN
oxytetracycline  ||| S:563 E:579 ||| NNS
( ||| S:579 E:580 ||| -LRB-
OTC ||| S:580 E:583 ||| NNP
)  ||| S:583 E:585 ||| -RRB-
in  ||| S:585 E:588 ||| IN
drinking  ||| S:588 E:597 ||| VBG
water  ||| S:597 E:603 ||| NN
over  ||| S:603 E:608 ||| IN
a  ||| S:608 E:610 ||| DT
five-day  ||| S:610 E:619 ||| JJ
period  ||| S:619 E:626 ||| NN
on  ||| S:626 E:629 ||| IN
diarrhoea ||| S:629 E:638 ||| NN
,  ||| S:638 E:640 ||| ,
faecal  ||| S:640 E:647 ||| VBZ
shedding  ||| S:647 E:656 ||| VBG
of  ||| S:656 E:659 ||| IN
LI  ||| S:659 E:662 ||| NNP
and  ||| S:662 E:666 ||| CC
average  ||| S:666 E:674 ||| JJ
daily  ||| S:674 E:680 ||| JJ
weight  ||| S:680 E:687 ||| NN
gain  ||| S:687 E:692 ||| NN
( ||| S:692 E:693 ||| -LRB-
ADG ||| S:693 E:696 ||| NNP
) ||| S:696 E:697 ||| -RRB-
.  ||| S:697 E:699 ||| .
A  ||| S:699 E:701 ||| DT
randomised  ||| S:701 E:712 ||| JJ
clinical  ||| S:712 E:721 ||| JJ
trial  ||| S:721 E:727 ||| NN
was  ||| S:727 E:731 ||| VBD
carried  ||| S:731 E:739 ||| VBN
out  ||| S:739 E:743 ||| RP
in  ||| S:743 E:746 ||| IN
four  ||| S:746 E:751 ||| CD
Danish  ||| S:751 E:758 ||| JJ
pig  ||| S:758 E:762 ||| NN
herds ||| S:762 E:767 ||| NNS
.  ||| S:767 E:769 ||| .
In  ||| S:769 E:772 ||| IN
total ||| S:772 E:777 ||| NN
,  ||| S:777 E:779 ||| ,
539  ||| S:779 E:783 ||| CD
animals  ||| S:783 E:791 ||| NNS
from  ||| S:791 E:796 ||| IN
37  ||| S:796 E:799 ||| CD
batches  ||| S:799 E:807 ||| NNS
of  ||| S:807 E:810 ||| IN
nursery  ||| S:810 E:818 ||| JJ
pigs  ||| S:818 E:823 ||| NNS
were  ||| S:823 E:828 ||| VBD
included  ||| S:828 E:837 ||| VBN
in  ||| S:837 E:840 ||| IN
the  ||| S:840 E:844 ||| DT
study ||| S:844 E:849 ||| NN
.  ||| S:849 E:851 ||| .
The  ||| S:851 E:855 ||| DT
dosage  ||| S:855 E:862 ||| JJ
regimens  ||| S:862 E:871 ||| NN
were  ||| S:871 E:876 ||| VBD
randomly  ||| S:876 E:885 ||| RB
allocated  ||| S:885 E:895 ||| VBN
to  ||| S:895 E:898 ||| TO
each  ||| S:898 E:903 ||| DT
batch  ||| S:903 E:909 ||| NN
and  ||| S:909 E:913 ||| CC
initiated  ||| S:913 E:923 ||| VBN
at  ||| S:923 E:926 ||| IN
presence  ||| S:926 E:935 ||| NN
of  ||| S:935 E:938 ||| IN
assumed  ||| S:938 E:946 ||| VBN
LI-related  ||| S:946 E:957 ||| JJ
diarrhoea ||| S:957 E:966 ||| NN
.  ||| S:966 E:968 ||| .
In  ||| S:968 E:971 ||| IN
general ||| S:971 E:978 ||| JJ
,  ||| S:978 E:980 ||| ,
all  ||| S:980 E:984 ||| DT
OTC  ||| S:984 E:988 ||| NNP
doses  ||| S:988 E:994 ||| VBD
used  ||| S:994 E:999 ||| VBN
for  ||| S:999 E:1003 ||| IN
the  ||| S:1003 E:1007 ||| DT
treatment  ||| S:1007 E:1017 ||| NN
of  ||| S:1017 E:1020 ||| IN
LI  ||| S:1020 E:1023 ||| NNP
infection  ||| S:1023 E:1033 ||| NN
resulted  ||| S:1033 E:1042 ||| VBD
in  ||| S:1042 E:1045 ||| IN
reduced  ||| S:1045 E:1053 ||| JJ
diarrhoea  ||| S:1053 E:1063 ||| NN
and  ||| S:1063 E:1067 ||| CC
LI  ||| S:1067 E:1070 ||| NNP
shedding  ||| S:1070 E:1079 ||| NN
after  ||| S:1079 E:1085 ||| IN
treatment ||| S:1085 E:1094 ||| NN
.  ||| S:1094 E:1096 ||| .
Treatment  ||| S:1096 E:1106 ||| NN
with  ||| S:1106 E:1111 ||| IN
a  ||| S:1111 E:1113 ||| DT
low  ||| S:1113 E:1117 ||| JJ
dose  ||| S:1117 E:1122 ||| NN
of  ||| S:1122 E:1125 ||| IN
5mg ||| S:1125 E:1128 ||| FW
/ ||| S:1128 E:1129 ||| FW
kg  ||| S:1129 E:1132 ||| FW
OTC  ||| S:1132 E:1136 ||| NNP
per  ||| S:1136 E:1140 ||| IN
kg  ||| S:1140 E:1143 ||| JJ
body  ||| S:1143 E:1148 ||| NN
weight ||| S:1148 E:1154 ||| NN
,  ||| S:1154 E:1156 ||| ,
however ||| S:1156 E:1163 ||| RB
,  ||| S:1163 E:1165 ||| ,
tended  ||| S:1165 E:1172 ||| VBD
to  ||| S:1172 E:1175 ||| TO
cause  ||| S:1175 E:1181 ||| VB
more  ||| S:1181 E:1186 ||| RBR
watery  ||| S:1186 E:1193 ||| JJ
faeces  ||| S:1193 E:1200 ||| NN
and  ||| S:1200 E:1204 ||| CC
resulted  ||| S:1204 E:1213 ||| VBD
in  ||| S:1213 E:1216 ||| IN
higher  ||| S:1216 E:1223 ||| JJR
odds  ||| S:1223 E:1228 ||| NNS
of  ||| S:1228 E:1231 ||| IN
pigs  ||| S:1231 E:1236 ||| NNS
shedding  ||| S:1236 E:1245 ||| VBG
LI  ||| S:1245 E:1248 ||| NNP
above  ||| S:1248 E:1254 ||| IN
detection  ||| S:1254 E:1264 ||| JJ
level  ||| S:1264 E:1270 ||| NN
when  ||| S:1270 E:1275 ||| WRB
compared  ||| S:1275 E:1284 ||| VBN
to  ||| S:1284 E:1287 ||| TO
medium  ||| S:1287 E:1294 ||| NN
and  ||| S:1294 E:1298 ||| CC
high  ||| S:1298 E:1303 ||| JJ
doses  ||| S:1303 E:1309 ||| NNS
( ||| S:1309 E:1310 ||| -LRB-
with  ||| S:1310 E:1315 ||| IN
odds  ||| S:1315 E:1320 ||| JJ
ratios  ||| S:1320 E:1327 ||| NNS
of  ||| S:1327 E:1330 ||| IN
5.5  ||| S:1330 E:1334 ||| CD
and  ||| S:1334 E:1338 ||| CC
8.4 ||| S:1338 E:1341 ||| CD
,  ||| S:1341 E:1343 ||| ,
respectively ||| S:1343 E:1355 ||| RB
) ||| S:1355 E:1356 ||| -RRB-
.  ||| S:1356 E:1358 ||| .
No  ||| S:1358 E:1361 ||| DT
association  ||| S:1361 E:1373 ||| NN
was  ||| S:1373 E:1377 ||| VBD
found  ||| S:1377 E:1383 ||| VBN
between  ||| S:1383 E:1391 ||| IN
the  ||| S:1391 E:1395 ||| DT
dose  ||| S:1395 E:1400 ||| NN
of  ||| S:1400 E:1403 ||| IN
OTC  ||| S:1403 E:1407 ||| NNP
and  ||| S:1407 E:1411 ||| CC
the  ||| S:1411 E:1415 ||| DT
ADG ||| S:1415 E:1418 ||| NNP
.  ||| S:1418 E:1420 ||| .
In  ||| S:1420 E:1423 ||| IN
conclusion ||| S:1423 E:1433 ||| NN
,  ||| S:1433 E:1435 ||| ,
a  ||| S:1435 E:1437 ||| DT
dose  ||| S:1437 E:1442 ||| NN
of  ||| S:1442 E:1445 ||| IN
5mg  ||| S:1445 E:1449 ||| NNP
OTC  ||| S:1449 E:1453 ||| NNP
per  ||| S:1453 E:1457 ||| IN
kg  ||| S:1457 E:1460 ||| JJ
body  ||| S:1460 E:1465 ||| NN
weight  ||| S:1465 E:1472 ||| NN
was  ||| S:1472 E:1476 ||| VBD
adequate  ||| S:1476 E:1485 ||| JJ
for  ||| S:1485 E:1489 ||| IN
reducing  ||| S:1489 E:1498 ||| VBG
the  ||| S:1498 E:1502 ||| DT
high-level  ||| S:1502 E:1513 ||| JJ
LI  ||| S:1513 E:1516 ||| NNS
shedding  ||| S:1516 E:1525 ||| VBG
associated  ||| S:1525 E:1536 ||| VBN
with  ||| S:1536 E:1541 ||| IN
enteropathy ||| S:1541 E:1552 ||| NN
,  ||| S:1552 E:1554 ||| ,
but  ||| S:1554 E:1558 ||| CC
a  ||| S:1558 E:1560 ||| DT
dose  ||| S:1560 E:1565 ||| NN
of  ||| S:1565 E:1568 ||| IN
10mg  ||| S:1568 E:1573 ||| NNP
OTC  ||| S:1573 E:1577 ||| NNP
per  ||| S:1577 E:1581 ||| IN
kg  ||| S:1581 E:1584 ||| JJ
body  ||| S:1584 E:1589 ||| NN
weight  ||| S:1589 E:1596 ||| NN
was  ||| S:1596 E:1600 ||| VBD
necessary  ||| S:1600 E:1610 ||| JJ
to  ||| S:1610 E:1613 ||| TO
obtain  ||| S:1613 E:1620 ||| VB
a  ||| S:1620 E:1622 ||| DT
maximum  ||| S:1622 E:1630 ||| JJ
reduction  ||| S:1630 E:1640 ||| NN
in  ||| S:1640 E:1643 ||| IN
LI  ||| S:1643 E:1646 ||| NNP
shedding ||| S:1646 E:1654 ||| NN
.  ||| S:1654 E:1656 ||| .
